These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30793706)

  • 1. Evaluation of adipose tissue and liver radiodensity in overweight or obese patients with nonalcoholic fatty liver disease.
    Kempiński R; Neubauer K; Hałoń A; Podgórski P; Dudkowiak R; Poniewierka E
    Pol Arch Intern Med; 2019 May; 129(5):354-356. PubMed ID: 30793706
    [No Abstract]   [Full Text] [Related]  

  • 2. FIB-4 Improves LSM-Based Prediction of Complications in Overweight or Obese Patients With Compensated Advanced Chronic Liver Disease.
    Mendoza YP; Shengir M; Bosch J; Sebastiani G; Berzigotti A
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2396-2398.e3. PubMed ID: 33716139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood.
    Yan Y; Hou D; Zhao X; Liu J; Cheng H; Wang Y; Mi J
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28356335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women.
    Corbould A; Bhathal PS; Dixon JB; O'Brien PE
    Metab Syndr Relat Disord; 2014 Aug; 12(6):311-9. PubMed ID: 24819229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice.
    Bijnen M; Josefs T; Cuijpers I; Maalsen CJ; van de Gaar J; Vroomen M; Wijnands E; Rensen SS; Greve JWM; Hofker MH; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
    Gut; 2018 Jul; 67(7):1317-1327. PubMed ID: 29074725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
    Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
    Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis.
    Kim B; Farruggia C; Ku CS; Pham TX; Yang Y; Bae M; Wegner CJ; Farrell NJ; Harness E; Park YK; Koo SI; Lee JY
    J Nutr Biochem; 2017 May; 43():27-35. PubMed ID: 28193580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Di Martino M; Versacci P; Andreoli G; Silvestri LM; Chiesa C
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):734-41. PubMed ID: 26026214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease.
    Allard J; Le Guillou D; Begriche K; Fromenty B
    Adv Pharmacol; 2019; 85():75-107. PubMed ID: 31307592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.
    Cimini FA; Barchetta I; Carotti S; Bertoccini L; Baroni MG; Vespasiani-Gentilucci U; Cavallo MG; Morini S
    World J Gastroenterol; 2017 May; 23(19):3407-3417. PubMed ID: 28596677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
    Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue, obesity and non-alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Mantzoros CS
    Minerva Endocrinol; 2017 Jun; 42(2):92-108. PubMed ID: 27711029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the relationship between non-alcoholic fatty liver disease and coronary artery disease.
    Topuz M; Dogan A; Celik A; Can C; Ozdogru I; Kemal Eryol N
    Clin Ter; 2014; 165(1):e46-51. PubMed ID: 24589960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic fat content and bone mineral density in children with overweight/obesity.
    Labayen I; Ruiz JR; Arenaza L; Medrano M; Tobalina I; Gracia-Marco L; Ortega FB; Rodriguez-Vigil B
    Pediatr Res; 2018 Nov; 84(5):684-688. PubMed ID: 30120405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Correlation Between Body Fat, Visceral Fat, and Nonalcoholic Fatty Liver Disease.
    Ko YH; Wong TC; Hsu YY; Kuo KL; Yang SH
    Metab Syndr Relat Disord; 2017 Aug; 15(6):304-311. PubMed ID: 28481662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NALPs in adipose and the fibrotic progression of non-alcoholic fatty liver disease in obese subjects.
    Mehta R; Neupane A; Wang L; Goodman Z; Baranova A; Younossi ZM
    BMC Gastroenterol; 2014 Dec; 14():208. PubMed ID: 25512222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.